Use of dppiv/seprase as a marker for cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01)

Patent

CA 2760735

The present invention relates to a method aiding in the assessment of cancer. It discloses the use of "soluble DPPIV/Seprase protein complex" (= DPPIV/Seprase) as a universal marker of different cancer types. Measurement of DPPIV/Seprase can, e.g., be used in the early detection or diagnosis of cancer or in the surveillance of patients who undergo surgery.

Cette invention concerne une méthode contribuant à l'évaluation du cancer. L'invention décrit l'utilisation d'un « complexe soluble DPPIV/séprase » (DPPIV/séprase) comme marqueur universel de différents types de cancer. La mesure du complexe DPPIV/séprase peut, par exemple, être utilisée pour détecter ou diagnostiquer précocement un cancer ou pour surveiller les patients subissant une chirurgie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of dppiv/seprase as a marker for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of dppiv/seprase as a marker for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dppiv/seprase as a marker for cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1977186

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.